Advertisement
CSWYF vs LYPHF
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CSWYF is a Buy and LYPHF is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CSWYF’s FA Score shows that 2 FA rating(s) are green whileLYPHF’s FA Score has 0 green FA rating(s).
- CSWYF’s FA Score: 2 green, 3 red.
- LYPHF’s FA Score: 0 green, 5 red.
Price Growth
CSWYF (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while LYPHF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.58%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was +30.64%.
Industries' Descriptions
@Pharmaceuticals: Generic (+0.58% weekly)A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.
| CSWYF | LYPHF | CSWYF / LYPHF | |
| Capitalization | 891M | 1.67B | 54% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 0.000 | -22.025 | - |
| P/E Ratio | 4.88 | 15.33 | 32% |
| Revenue | N/A | N/A | - |
| Total Cash | N/A | N/A | - |
| Total Debt | N/A | N/A | - |
| CSWYF | LYPHF | |
|---|---|---|
| RSI ODDS (%) | N/A | N/A |
| Stochastic ODDS (%) | N/A | N/A |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 3 days ago 13% | 3 days ago 5% |
| TrendMonth ODDS (%) | 3 days ago 14% | 3 days ago 4% |
| Advances ODDS (%) | N/A | N/A |
| Declines ODDS (%) | N/A | N/A |
| BollingerBands ODDS (%) | N/A | N/A |
| Aroon ODDS (%) | N/A | N/A |
Advertisement
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NPNAX | 52.62 | 0.21 | +0.40% |
| Neuberger Berman Large Cap Value A | |||
| BIERX | 28.36 | 0.06 | +0.21% |
| Brandes International Equity R6 | |||
| MISFX | 15.03 | 0.03 | +0.20% |
| Matthews Emerging Markets Sust Fut Inst | |||
| BGATX | 19.16 | -0.04 | -0.23% |
| Baillie Gifford Global Alpha Equities 2 | |||
| WCPIX | 57.35 | -0.49 | -0.85% |
| Communication Services UltraSectorProInv | |||
CSWYF and
Correlation & Price change
A.I.dvisor tells us that CSWYF and HAWPF have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CSWYF and HAWPF's prices will move in lockstep.
| Ticker / NAME | Correlation To CSWYF | 1D Price Change % | ||
|---|---|---|---|---|
| CSWYF | 100% | N/A | ||
| HAWPF - CSWYF | 27% Poorly correlated | N/A | ||
| SNYNF - CSWYF | 3% Poorly correlated | N/A | ||
| MIRA - CSWYF | 1% Poorly correlated | -1.38% | ||
| SCLX - CSWYF | 1% Poorly correlated | +0.32% | ||
| LYPHF - CSWYF | 1% Poorly correlated | N/A | ||
More | ||||
LYPHF and
Correlation & Price change
A.I.dvisor tells us that LYPHF and OGN have been poorly correlated (+4% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LYPHF and OGN's prices will move in lockstep.
| Ticker / NAME | Correlation To LYPHF | 1D Price Change % | ||
|---|---|---|---|---|
| LYPHF | 100% | N/A | ||
| OGN - LYPHF | 4% Poorly correlated | +2.53% | ||
| SNYNF - LYPHF | 3% Poorly correlated | N/A | ||
| CSWYF - LYPHF | 1% Poorly correlated | N/A | ||
| VRBCF - LYPHF | -0% Poorly correlated | N/A | ||
| JCRRF - LYPHF | -1% Poorly correlated | N/A | ||
More | ||||